Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × sargramostim × 90 days × Clear all

Sponsor

Conditions

Neuroblastoma 5 Triple Negative Breast Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Ganglioneuroblastoma 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Leukemia 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Adenoma, Islet Cell 1

Interventions

Specimen Handling 7 Biopsy 6 fludarabine 3 ruxolitinib 2 decitabine and cedazuridine drug combination 2 Tacrolimus 2 Injections 2 Decitabine 2 Cyclophosphamide 2 Busulfan 2 Azacitidine 2 venetoclax 1 veliparib 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 fludarabine phosphate 1 fedratinib 1 axatilimab 1 Topotecan 1 Thiotepa 1 Succimer 1 Stem Cell Transplantation 1 Pentetic Acid 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡